Arteris (AIP) Earnings Date & Reports

Key Takeaways

• Arteris reported third quarter 2026 revenue of $25.8 million, up 48% year over year and above the top end of its guidance range.
• Non-GAAP net loss narrowed to $0.02 per share, beating consensus estimates, while GAAP net loss widened to $0.23 per share.
• Annual Contract Value (ACV) plus royalties hit a record $103.8 million, up 39% year over year, and Remaining Performance Obligations (RPO) reached a record $135 million.
• Management raised full-year 2026 guidance across revenue, ACV plus royalties, and non-GAAP operating income.
• Trailing twelve-month royalties rose 71% to $9.4 million, signaling growing production volumes of customer chips embedding Arteris technology.
• Free cash flow swung to negative $2.1 million in the quarter, attributed to customer payment timing, while cash and investments totaled $120 million with no financial debt.
• For more on this ticker's Major News, Today's Price Move, Price Targets, and Forecast, explore the dedicated Arteris pages.
• Explore Trending AI Robots to discover AI-driven trading strategies and market insights.

Earnings Context and Why It Matters

Arteris is a leading provider of system IP (intellectual property), specializing in Network-on-Chip (NoC) interconnect technology that accelerates the creation of complex system-on-chip (SoC) and multi-die chiplet designs. Its results matter because they offer a read on demand for the high-performance, power-efficient silicon powering artificial intelligence (AI) infrastructure, data centers, and physical AI applications. After accelerating revenue growth for three straight quarters, Arteris entered this report under pressure, with its shares trading well below prior highs. The third quarter report was a key test of whether the company could sustain momentum, convert record bookings into margin improvement, and continue its march toward non-GAAP profitability.

Reported Results

For the third quarter ended September 30, 2026, Arteris posted record revenue of $25.8 million, a 48% increase from $17.4 million a year earlier and above the consensus estimate of roughly $24.5 million. Non-GAAP net loss narrowed to $0.02 per diluted share, beating the consensus expectation of a roughly $0.04 per share loss. On a GAAP basis, however, net loss widened to $11.2 million, or $0.23 per share, driven in part by $9.2 million in stock-based compensation and acquisition-related amortization.

Operating metrics reflected a strong demand picture. ACV plus royalties reached a record $103.8 million, up 39% year over year, while RPO, which represents contracted future revenue, rose to a record $135 million. Trailing twelve-month variable royalties climbed 71% to $9.4 million, a signal that customer designs embedding Arteris technology are shipping at higher volumes. The company also surpassed 1,000 confirmed design starts since inception.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps surface trade ideas, trending stocks, breakout candidates, and market opportunities far more efficiently than manual screening. For investors tracking semiconductor and AI-related names such as Arteris, it offers a practical way to monitor shifting momentum and technical setups alongside fundamental developments.

Market Reaction and Investor Sentiment

Despite the headline beat and raised guidance, shares sold off sharply in the aftermath of the report, reflecting a market focused on the details beneath the surprise. Investors weighed the widening GAAP loss, a sequential slowdown in ACV-plus-royalties growth, and the swing to negative quarterly free cash flow. Dilution from a prior at-the-market equity offering also remained a point of concern. At the same time, the fundamental narrative improved: revenue growth accelerated, royalties compounded, and the company moved to the edge of non-GAAP profitability. The reaction underscored a stock caught between a strengthening underlying business and near-term execution and cash-flow questions.

Forward Outlook and Key Factors to Monitor

Arteris raised its full-year 2026 outlook and issued fourth quarter guidance that leaves a first non-GAAP profitable quarter within reach. For the fourth quarter, management expects ACV plus royalties of $103 million to $107 million, revenue of $25.7 million to $26.7 million, and non-GAAP operating results ranging from a $0.9 million loss to a $1.1 million gain. Full-year revenue guidance was raised to $98.5 million to $99.5 million.

Investors should watch whether the third quarter's softer sequential ACV growth was a timing issue rather than a shift in deal momentum, and whether RPO resumes meaningful growth. Cash collection will also be closely monitored, given that management left its full-year free cash flow target of $5 million to $9 million unchanged despite negative year-to-date free cash flow, implying a heavy fourth quarter collection burden.

Longer term, the expanding role of chiplets and multi-die architectures stands out as a key catalyst. Management noted that chiplets represent about 10% of design starts today and are expected to approach 35% within two to three years, which could support higher average selling prices for Arteris's newer FlexGen and Ncore Multi-Die products. Royalty growth, which reflects actual customer chip shipments, remains the most important long-term signal to track.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations